Platform
SomaBiome is developing a non-invasive platform to support clinician-led diagnosis of fibromyalgia.
The somaBiome Report
Our core product is a one-page clinical decision support report designed for rapid integration into specialist workflows.
- Likelihood Score: An objective assessment derived from host–microbe models developed and evaluated in published research cohorts.
- Interpretable Microbial Markers: Specific bacterial signatures correlated with fibromyalgia status and symptom severity.
- Clinical Context: Clear summaries that supplement standard exclusion-based diagnostic protocols.
Process Flow
01. Sample
Patient sample collection in a clinical setting.
02. Sequencing
High-throughput sequencing at partner laboratories.
03. Report
Computational analysis and report generation.
Core Components
Rigorous QA
Reproducible computational pipelines with hardened audit trails.
Interpretability
Models designed to prioritize biological relevance over "black-box" predictions.
Clinical decision support under development. Not for consumer use.